NCT00160277已完成3 期
Open Label, Multi-Center, Force-Titration Study to Evaluate the Efficacy and Safety of Moxonidine in Ambulatory Subjects With Essential Hypertension
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 100
- 试验地点
- 3
- 主要终点
- Systolic blood pressure reduction
研究概览
简要总结
The purpose of this study is to demonstrate efficacy and safety of Moxonidine in Indian subjects.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Hypertension
排除标准
- •Severe concomitant diseases, CHF, secondary hypertension, severe hypertension, significant hepatic disease, unstable angina
结局指标
主要结局
Systolic blood pressure reduction
次要结局
- Piggy-back pharmacoeconomic evaluation; Safety and tolerability
研究者
研究点 (3)
Loading locations...
相似试验
招募中
不适用
Moxibustion Reduces Symptoms and Improves Quality of Life in Patients With Allergic RhinitisAllergic RhinitisNCT06173882Henan University of Traditional Chinese Medicine90
已完成
3 期
A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired PneumoniaPneumoniaNCT00717561Bayer60
已完成
不适用
Moxy Drug Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Femoropopliteal ArteriesFemoral Artery StenosisPopliteal Artery StenosisFemoral Artery OcclusionPopliteal Artery OcclusionNCT01412541C. R. Bard532
终止
3 期
Moxonidine in Patients Undergoing Vascular SurgeryCardiac DiseaseVascular SurgeryNCT00244504University Hospital, Basel, Switzerland141
已完成
3 期
Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal InfectionIntraabdominal InfectionsNCT01069900Bayer458